High expression levels of PDGFR-β and α-SMA in stromal CAFs compared to the tumor cells supported the clear difference between CAFs and parenchymal cancer cells, similarly to what previous studies have reported 30, 61. The gene discussed is ACTA1; the disease is cancer.